menu
    • menu

    Company profile for Medicus Pharma

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medicus Pharma Ltd is a biotech company focused on advancing novel therapeutic assets through clinical development. With extensive industry experience, the company aims to improve patient safety and efficacy by addressing unmet medical needs. Medicus follows a collaborative process to identify and advance promising clinical-stage assets. Additionally, the company is exploring opportunities for pipeline expansion through strate...
    Medicus Pharma Ltd is a biotech company focused on advancing novel therapeutic assets through clinical development. With extensive industry experience, the company aims to improve patient safety and efficacy by addressing unmet medical needs. Medicus follows a collaborative process to identify and advance promising clinical-stage assets. Additionally, the company is exploring opportunities for pipeline expansion through strategic acquisitions and partnerships.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Medicus PharmaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    100 King St W Suite 3400, Toronto, ON M5X 1A4
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://medicuspharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicus Pharma Announces SkinJect Phase 2 Data Review
    Medicus Pharma Announces SkinJect Phase 2 Data Review

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256157/0/en/Medicus-Pharma-Announces-SkinJect-Phase-2-Principal-Investigator-and-Key-Opinion-Leader-KOL-Babar-K-Rao-MD-FAAD-to-Provide-Clinical-Interpretation-of-Positive-Data-During-Business-.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Medicus Pharma To Join Longwood Miami CEO Forum
    Medicus Pharma To Join Longwood Miami CEO Forum

    10 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-10/medicus-pharma-ltd-to-participate-in-the-longwood-miami-ceo-forum

    PHARMIWEB
    10 Mar 2026
    Share Share
    Medicus Pharma To Participate In The 38Th Annual Roth Conference
    Medicus Pharma To Participate In The 38Th Annual Roth Conference

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248225/0/en/Medicus-Pharma-To-Participate-in-the-38th-Annual-Roth-Conference.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Medicus Pharma on Bloomberg World
    Medicus Pharma on Bloomberg World

    12 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-12/medicus-pharma-on-bloomberg-world

    PHARMIWEB
    12 Feb 2026
    Share Share
    Medicus Gets FDA OK to Start Teverelix Ph 2b Prostate Study
    Medicus Gets FDA OK to Start Teverelix Ph 2b Prostate Study

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235197/0/en/Medicus-Pharma-Receives-FDA-Study-May-Proceed-Clearance-For-Teverelix-Phase-2b-Study-in-Advanced-Prostate-Cancer-Patients-with-High-Cardiovascular-Risk.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Medicus Pharma Celebrates Nasdaq Anniversary With Opening Bell
    Medicus Pharma Celebrates Nasdaq Anniversary With Opening Bell

    23 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-23/medicus-pharma-marks-nasdaq-anniversary-with-opening-bell-ceremony

    PHARMIWEB
    23 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search